Trial Profile
TACE plus sorafenib VS TACE monotherapy for the treatment of Multi-nodular hepatocellular carcinoma (Stage BCLC B): A prospective, multi-center comparison study
Status:
Not yet recruiting
Phase of Trial:
Phase IV
Latest Information Update: 29 Apr 2016
Price :
$35
*
At a glance
- Drugs Sorafenib (Primary)
- Indications Liver cancer
- Focus Therapeutic Use
- 29 Apr 2016 New trial record